Assessing Two Coenzyme Q10 Products in Men and Women

The goal of this clinical trial is to compare the relative bioavailability of coenzyme Q10 (CoQ10) from acute administrations of a CoQ10 product designed for enhanced absorption versus a standard CoQ10 product in healthy men and women. Participants will be asked to come to the clinical on five different occasions, including a screening visit (visit 1, -7 days), two test 1 visits (visits 2 and 3, days 0 and 1), and two test 2 visits (visits 4 and 5, days 7 and 8). During the start of each test visit (visits 2 and 4), the participant will consume each study product with water and a standardized breakfast meal. Then, blood samples will be collected over a 10-hour period, and a standardized lunch, dinner, and snacks will be provided. The participant will return to the clinic the next morning for a blood draw 24 hours after the study product ingestion from the previous day. The same procedures will be repeated 7 to 14 days later with the other study product.

NCT Number	NCT07530250
Lead Sponsor	Midwest Center for Metabolic and Cardiovascular Research Collaborators: Pharmavite LLC
Conditions	CoQ10 Blood Levels
Enrollment	24 participants
Start Date	2026-05-18
Primary Completion	2026-07-01 (estimated)
Study Completion	2026-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-21